Logo Université Laval Logo Université Laval
International Chair on Cardiometabolic Risk
My Healthy Waist

Documentation centre

10189-10200 of 10210 results
Page 850 of 851
Key Publications August 30, 2007

Circulating oxidised low-density lipoprotein and intercellular adhesion molecule-1 and risk of type 2 diabetes mellitus: the Atherosclerosis Risk in Communities study.

Diabetologia 2007;50:36-42

Hoogeveen RC, Ballantyne CM, Bang H et al.
Diabetes Inflammation Lipids/Lipoproteins
Key Publications August 30, 2007

Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.

N Engl J Med 2001;344:1343-50

Tuomilehto J, Lindström J, Eriksson JG et al.
Diabetes Prevention
Key Publications August 30, 2007

Genetics of apolipoprotein B and apolipoprotein A1 and premature cardiovascular disease.

J Internal Med 2006;259:473-80

Zambon A, Brown BG, Deeb S, Brunzell JD
Cardiovascular Disease Genetics Lipids/Lipoproteins
Key Publications August 30, 2007

Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study.

Circulation 2003;107:448-54

Rutter MK, Parise H, Benjamin EJ et al.
Insulin Resistance Sex Differences
Key Publications August 30, 2007

Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.

Arch Intern Med 2005;165:2479-84

Ballantyne CM, Hoogeveen RC, Bang H et al.
Inflammation Lipids/Lipoproteins
Key Publications August 30, 2007

Genetically determined apo B levels and peak LDL density angiographic response to intensive lipid-lowering therapy.

J Internal Med 2006;259:401-9

Zambon A, Brown BG, Hokanson JE, Motulsky AG, Brunzell JD
Lipids/Lipoproteins
Key Publications August 30, 2007

Small, dense LDL (sdLDL) and elevated apo B are the common characteristics for the 3 major lipid phenotypes of FCHL.

Arterioscler Thromb Vasc Biol 2003;23:1289-94

Ayyobi AF, McGladdery SH, McNeely MJ, Austin MA, Motulsky AG, Brunzell JD
Lipids/Lipoproteins
Key Publications August 30, 2007

Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.

J Intern Med 2006;259:247-58

Barter PJ, Ballantyne CM, Carmena R et al.
Lipids/Lipoproteins
Key Publications August 30, 2007

Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity.

J Clin Invest 2005;115:1298-305

Osei-Hyiaman D, DePetrillo M, Pacher P et al.
Lipids/Lipoproteins Metabolism: Animal Studies Obesity
Key Publications August 30, 2007

Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men?

Circulation 2000;102:179-84

Lemieux I, Pascot A, Couillard C et al.
Metabolic Syndrome
Key Publications August 30, 2007

Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report.

Circulation 2002;106:3143-421

National Cholesterol Education Program (NCEP)
Metabolic Syndrome
Key Publications August 30, 2007

Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease.

JAMA 1998;279:1955-61

Lamarche B, Tchernof A, Mauriège P et al.
Metabolic Syndrome
of 851